Related Experiment Video

Updated: Aug 14, 2026

An Orthotopic Murine Model of Human Prostate Cancer Metastasis
06:48

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

Drug resistant cells with very large proliferative potential grow exponentially in metastatic prostate cancer

Krastan B Blagoev1,2, Roumen Iordanov3, Mengxi Zhou4,5

  • 1National Science Foundation, Alexandria, VA 22230, USA.

Oncotarget
|January 18, 2021
PubMed

Insights

Drug-resistant cancer cells drive metastatic growth. These metastasis-causing cells (MCC) form exponentially growing tumors, leading to continued tumor burden despite various treatments in patients with metastatic prostate cancer.

Area of Science:

  • Oncology
  • Cancer Biology
  • Mathematical Biology

Background:

  • Metastatic cancers often develop drug resistance during treatment.
  • Phenotypically plastic, stem-cell-like cancer cells are implicated in metastasis formation.
  • The population structure and growth dynamics of metastatic tumors remain poorly understood.

Purpose of the Study:

  • To investigate the population structure and growth dynamics of drug-resistant cells in metastatic tumors.
  • To determine the role of metastasis-causing cells (MCC) in tumor growth during treatment.

Main Methods:

  • Utilized scaling analysis of clinical data.
  • Analyzed tumor burden data from patients with metastatic prostate cancer.

Main Results:

  • Identified drug-resistant metastasis-causing cells (MCC) as a key driver of tumor growth.
  • Demonstrated that MCC can generate exponentially growing, drug-resistant tumors.
  • Showed that these tumors contribute to sustained tumor burden throughout different treatment regimens.

Conclusions:

  • Drug-resistant metastasis-causing cells (MCC) are responsible for the growth of metastatic tumors.
  • The inherent properties of MCC lead to exponential tumor growth and resistance to therapy.
  • Understanding MCC dynamics is crucial for developing effective treatments for metastatic cancers.
Keywords:
cancer stem cellsdrug resistanceexponential growthmetastatic prostate cancertumor kinetics

More Related Videos

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel06:44

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

Published on: September 8, 2017

Prostate Organoid Cultures as Tools to Translate Genotypes and Mutational Profiles to Pharmacological Responses08:36

Prostate Organoid Cultures as Tools to Translate Genotypes and Mutational Profiles to Pharmacological Responses

Published on: October 24, 2019

Related Concept Videos

Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...